PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Baxter Healthcare ×

UPDATED
Regulatorische Updates
10. Sept. 2026•1 Min. Lesezeit
FDA Approves TRANSDERM SCOP (NDA017874) Transdermal Scopolamine Patch
The FDA has approved the prescription transdermal patch TRANSDERM SCOP, containing 1 mg scopolamine per 72 hr, under NDA 017874. Baxter Healthcare is the manufacturer.
UPDATED
Regulatorische Updates
5. Sept. 2026•1 Min. Lesezeit
FDA Approves Sorbitol 3% Irrigation Solution (NDA017863)
The FDA granted approval for Baxter Healthcare's prescription Sorbitol 3% irrigation solution (NDA017863), a human drug administered via irrigation.